The newest episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features Tim Barry ‘93, the chair and CEO of VillageMD, and this year’s Cornell Entrepreneur of the Year. Entrepreneurship at Cornell will honor Barry on April 11 and 12 during the Celebration event on campus.
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
The hormone estrogen regulates binge drinking in females, causing them to “pregame” – consume large quantities of alcohol in the first 30 minutes after it’s offered, according to a preclinical study led by scientists at Weill Cornell Medicine.
Inhibiting an immune signaling protein may help preserve the protective layer surrounding nerve fibers in the brain during both Alzheimer’s disease and ordinary aging, a new study suggests.
A new protocol can detect and remove fake data created by bots and humans attempting to enroll in online research studies, in order to prevent biased results and unwarranted payments to bad actors – the first such protocol specifically designed for data collected in rural communities.
The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.
Faculty and staff within Cornell’s Department of Public & Ecosystem Health have been funded by the U.S. Centers for Disease Control and Prevention’s (CDC) National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce to help strengthen the public health system in the United States.
Weill Cornell Medicine researchers have determined the full-length structure and function of a blood pressure-regulating hormone receptor, which may enable better drug targeting of the receptor for diseases such as hypertension and heart failure.
Greater understanding of beneficial characteristics of the human brain, such as flexibility and reliability, will help Wenbo Tang develop therapies for human diseases – and to improve AI systems.